META vs ORCL: Which Is the Better Buy?

Side-by-side comparison of Meta Platforms, Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
Meta Platforms, Inc. Β· Communication Services
$665.60
+21.4% upside to fair value
Med Conviction Grade B+ High Quality
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric META ORCL
Current Price $665.60 $149.12
Fair Value Estimate $808.00 $216.22
Upside to Fair Value +21.4% +45.0%
Market Cap $1,695.6B $429.5B
Forward P/E β€” β€”
EV / EBITDA 16.7x 14.6x
Price / Sales 7.4x 6.0x
Price / FCF 41.3x β€”
Revenue Growth YoY +28.0% +29.6%
Gross Margin 81.7% 63.9%
Operating Margin 38.1% 32.4%
Return on Equity 29.7% 42.6%
Dividend Yield 0.32% 1.34%
FCF Yield 2.42% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
META β€” Meta Platforms, Inc.
Meta Platforms operates the Facebook, Instagram, WhatsApp, Messenger and Threads ecosystem, monetizing its unmatched global audience primarily through digital advertising. Business quality is high, supported by 3.60 billion Family daily active people, AI-enhanced ad ranking, 81.7% TTM gross margin, 38.1% TTM operating margin, 29.8% TTM net margin and 29.7% ROE. Revenue grew 28.0% year over year i…
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric META ORCL
Zone Low $606.00 $162.16
Zone High $686.80 $183.79
In Buy Zone? Yes Yes
← META Research    ORCL Research β†’    All Research